Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers A > Headlines for Advanced Influenza Technologies, Inc. > News item |
CytoDyn acquires Advanced Influenza Technologies from UTEK Corp.
By E. Janene Geiss
Philadelphia, July 21 - CytoDyn, Inc. and UTEK Corp. announced Friday that CytoDyn has acquired Advanced Influenza Technologies, Inc., a wholly owned subsidiary of UTEK, in a stock transaction.
The acquisition includes the license to a DNA-based influenza vaccine developed at the University of Massachusetts Medical School in Worcester, Mass., according to a company news release.
CytoDyn is a Santa Fe, N.M., biopharmaceutical company.
UTEK is a specialty finance company focused on technology transfer.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.